BeStock  
Markets › Compare › RARE vs MGRT

RARE vs MGRT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
RARE · Ultragenyx Pharmaceutical$14.50 ▼ 4.73%
MGRT · Mega Fortune$103.99 ▲ 0.95%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

-133690151223353157Oct 7, '25Apr 7, '26Oct 5, '26
  • RARE -51.2%
  • MGRT +2,080.1%

Head to head

MetricRAREMGRT
Price$14.50$103.99
Change today▼ 4.73%▲ 0.95%
Market cap$1.43B$1.43B
Return, 3 months-59.6%+39.6%
Return, year to date-37.0%+1,284.7%
Return, 1 year-52.0%+2,048.6%
P/E (TTM)-2.5799.9
P/B-4.991.9
P/E percentile vs own 5y––
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)3542
30-day volatility178.1%72.9%
Max drawdown, 1 year-64.8%-63.1%
Trend readStrong downtrendLeaning bearish
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MGRT is the largest of the group by market value.
  • MGRT has returned the most over the past year.
  • RARE carries the lowest trailing P/E.
  • MGRT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top